Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03701321 · WITHDRAWN
Trial details
- NCT number
- NCT03701321
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2020-05-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.